Table 1.
Characteristics | Peptide dose | ||
---|---|---|---|
0.5 mg (n = 3) | 1.0 mg (n = 3) | 2.0 mg (n = 4) | |
Median age (range), years | 58 (58–65) | 64 (58–70) | 57 (30–84) |
Male/female | 1/2 | 1/2 | 3/1 |
Performance status (0/1) | 1/2 | 0/3 | 0/4 |
Non‐small‐cell lung cancer | 1 | 1 | 2 |
Gastric cancer | 0 | 1 | 2 |
Colorectal cancer | 1 | 1 | 0 |
Thyroid cancer | 1 | 0 | 0 |